These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4083271)

  • 1. Phase 1 trial of levonantradol in chemotherapy-induced emesis.
    Tyson LB; Gralla RJ; Clark RA; Kris MG; Bordin LA; Bosl GJ
    Am J Clin Oncol; 1985 Dec; 8(6):528-32. PubMed ID: 4083271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose ranging evaluation of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis.
    Stambaugh JE; McAdams J; Vreeland F
    J Clin Pharmacol; 1984; 24(11-12):480-5. PubMed ID: 6392353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind multiple-dose crossover study of the antiemetic effect of intramuscular levonantradol compared to prochlorperazine.
    Sheidler VR; Ettinger DS; Diasio RB; Enterline JP; Brown MD
    J Clin Pharmacol; 1984 Apr; 24(4):155-9. PubMed ID: 6373843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral levonantradol in the treatment of chemotherapy-induced emesis: preliminary observations.
    Diasio RB; Ettinger DS; Satterwhite BE
    J Clin Pharmacol; 1981; 21(S1):81S-85S. PubMed ID: 7298876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiemetic effect of intramuscular levonantradol in patients receiving anticancer chemotherapy.
    Cronin CM; Sallan SE; Gelber R; Lucas VS; Laszlo J
    J Clin Pharmacol; 1981; 21(S1):43S-50S. PubMed ID: 7028793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levonantradol for chemotherapy-induced emesis: phase I-II oral administration.
    Laszlo J; Lucas VS; Hanson DC; Cronin CM; Sallan SE
    J Clin Pharmacol; 1981; 21(S1):51S-56S. PubMed ID: 7298875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
    Citron ML; Herman TS; Vreeland F; Krasnow SH; Fossieck BE; Harwood S; Franklin R; Cohen MH
    Cancer Treat Rep; 1985 Jan; 69(1):109-12. PubMed ID: 2981616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy.
    Joss RA; Galeazzi RL; Bischoff A; Do DD; Goldhirsch A; Brunner KW
    Cancer Chemother Pharmacol; 1982; 9(1):61-4. PubMed ID: 7139853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with levonantradol hydrochloride in the prevention of cancer chemotherapy-induced nausea and vomiting.
    Heim ME; Romer W; Queisser W
    J Clin Pharmacol; 1981; 21(S1):86S-89S. PubMed ID: 7298877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy.
    Hutcheon AW; Palmer JB; Soukop M; Cunningham D; McArdle C; Welsh J; Stuart F; Sangster G; Kaye S; Charlton D
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1087-90. PubMed ID: 6352278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy.
    Heim ME; Queisser W; Altenburg HP
    Cancer Chemother Pharmacol; 1984; 13(2):123-5. PubMed ID: 6467496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
    Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Tominaga K; Sakurai M; Sano T; Taito H; Takahashi H
    Jpn J Clin Oncol; 1986 Sep; 16(3):279-87. PubMed ID: 3534348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of cannabinoids and their antiemetic effectiveness.
    Vincent BJ; McQuiston DJ; Einhorn LH; Nagy CM; Brames MJ
    Drugs; 1983 Feb; 25 Suppl 1():52-62. PubMed ID: 6301800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy.
    Smith DB; Newlands ES; Rustin GJ; Begent RH; Howells N; McQuade B; Bagshawe KD
    Lancet; 1991 Aug; 338(8765):487-90. PubMed ID: 1714532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An all oral antiemetic regimen for patients undergoing high-dose chemotherapy with peripheral blood stem cell transplant.
    Frakes LA; Brehm TL; Kosty MP; Miller WE; McMillan RL; Mason J; Meisenberg BR
    Bone Marrow Transplant; 1997 Sep; 20(6):473-8. PubMed ID: 9313880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-ranging evaluation of the substituted benzamide dazopride when used as an antiemetic in patients receiving anticancer chemotherapy.
    Grant SC; Kris MG; Gralla RJ; Clark RA; Tyson LB
    Cancer Chemother Pharmacol; 1993; 31(6):442-4. PubMed ID: 8453682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicin.
    Cleri LB; Kris MG; Tyson LB; Pisters KM; Clark RA; Gralla RJ
    Cancer; 1995 Sep; 76(5):774-8. PubMed ID: 8625179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of refractory cytostatic agent-induced vomiting with the synthetic cannabinoid levonantradol].
    Heim ME; Queisser W
    Onkologie; 1982 Apr; 5(2):94-6. PubMed ID: 7048169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-ranging antiemetic evaluation of the serotonin antagonist RG 12915 in patients receiving anticancer chemotherapy.
    Baltzer L; Kris MG; Tyson LB; Rigas JR; Vreeland F; Pisters KM
    Cancer; 1993 Nov; 72(9):2695-9. PubMed ID: 8402492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral levonantradol in the control of cancer chemotherapy-induced emesis.
    Welsh J; Stuart F; Sangster G; Milstead R; Kaye S; Cash H; Charlton D; Calman K
    Cancer Chemother Pharmacol; 1983; 11(1):66-7. PubMed ID: 6684000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.